Anti-cancer composition comprising alginate
Biologically acceptable composition for the prophylaxis and/or treatment of colorectal cancer. The composition contains an iron chelator, and the composition is adapted for the selective targeting of the iron chelator to the colon. The iron chelator is non-digestible, non-absorbable and non-fermentable in the gastrointestinal tract.
1. A method of treating a mammal afflicted with colorectal cancer, the method comprising the oral administration to a mammal in need of a therapeutically effective amount of a biologically acceptable composition comprising an iron chelator, wherein the composition is encapsulated or microencapsulated by a coating which remains intact while the composition passes through the stomach and small intestine, but which degrades in the colon, such that the iron chelator is prevented from binding iron until it reaches the colon, and wherein the iron chelator is non-digestible, non-absorbable and non-fermentable in the gastrointestinal tract.
2. A method according to claim 1 , wherein the iron chelator is alginate.
3. A method according to claim 2 , wherein the amount of alginate administered is no more than 15 g per day.